Exendin (7-39) corresponds to a GLP-1 receptor-targeting fragment lacking the first six residues. The peptide retains much of the helical framework, allowing exploration of partial agonism and competitive interactions. Researchers use it to probe binding interfaces and structural determinants of receptor modulation. Its defined truncation aids detailed structure-activity analyses.
CAT No: E10010
2. Myotropic activity of allatostatins in tenebrionid beetles
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More